Written Question·Department of Health and Social Care·UIN 3455

Trastuzumab Deruxtecan

Tabled: 30 August 2024

Answered: 9 September 2024

Question

Adam Jogee

To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of Enhertu in reducing the number of women who lose their lives to breast cancer in (a) Newcastle-under-Lyme constituency and b) England.

Answer

Karin Smyth

Whilst we have made no specific assessment, the clinical trial evidence considered by the National Institute for Health and Care Excellence (NICE) shows that Enhertu increases how long people live and how long they have before their cancer gets worse comp...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 3455) →